期刊文献+

CⅡTA-pI在树突状细胞中特异启动活性的研究 被引量:2

Specific promoter activity of CⅡTA-pI in dendritic cells
原文传递
导出
摘要 目的 :检测MHCⅡ类分子反式激活因子Ⅰ型启动子 (CIITA pI)是否具有启动活性及其在树突状细胞 (dendriticcell,DC)中的特异启动活性。方法 :利用荧光素酶报告系统 ,检测仅 112bp的Ⅰ型CIITA pI在DC中的特异启动活性及报告基因在DC不同成熟程度下的表达。结果 :该启动子在DC中能够特异启动报告基因的表达 ,而在非DC细胞中几乎无启动活性 ;其启动活性随DC的成熟程度而上升。结论 :为进一步应用CIITA AIM: To detect whether CIITA-pI can drive reporter gene expression and its specific promoter activity in DCs. METHODS: Luciferase reporter system was used to detect 112 bp CIITA-pI-specific promoter activity in DCs. RESULTS: CⅡTA-pI could drive expression of reporter gene in DCs but not in HEK 293 cells and its promoter activity increased with the maturation of DCs. CONCLUSION: Our work provides a basis for further study of targeting DC gene therapy using CⅡTA-pI as DC-specific promoter.
作者 张燕 沈茜
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2004年第1期55-57,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目 (No .39970 2 70 )
关键词 树突状细胞 CⅡTA 启动子 dendritic cells CⅡTA promoter
  • 相关文献

参考文献7

  • 1[1]Morita A, Ariizumi K, Ritter R, et al. Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoter [J]. Gene Ther, 2001, 8(22): 1729-1737.
  • 2[2]Bonkobara M, Zukas PK, Shikano S, et al. Epidermal Langerhans cell-targeted gene expression by a dectin-2 promoter[J]. J Immunol, 2001, 167(12): 6893-6900.
  • 3[3]Brocker T. The role of dendritic cells in T cell selection and survival[J]. J Leukoc Biol, 1999, 66(2): 331-335.
  • 4[4]Zabel MD, Byrne BL, Weis JJ, et al. Cell-specific expression of the murine CD21 gene depends on accessibility of promoter and intronic elements[J]. J Immunol, 2000, 165(8): 4437-4445.
  • 5[5]Muhlethaler-Mottet A, Otten LA, Steimle V, et al. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA[J]. EMBO, 1997, 16(10): 2851-2860.
  • 6[6]Piskurich JF, Wang Y, Linhoff MW, et al. Identification of distinct regions of 5′ flanking DNA that mediate constitutive IFN-γ, STAT1, and TGF-β-regulated expression of the class II transactivator gene[J]. J Immunol, 1998, 160: 233-240.
  • 7[7]Piskurich JF, Linhoff MW, Wang Y, et al. Two distinctγinterferon -inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor1, and transforming growth factorβ[J]. Mol Cell Biol, 1999, 19(1): 431-440.

同被引文献21

  • 1曾浩,李虹,李响,杨宇如,王芳,吴琦.前列腺特异性膜抗原启动子增强子调控重组质粒的构建及鉴定[J].中华泌尿外科杂志,2005,26(6):371-374. 被引量:6
  • 2李红梅,宋天保,于月成,黄红艳,张明.人端粒酶逆转录酶基因核心启动子调控的肿瘤细胞特异性表达载体的构建[J].细胞与分子免疫学杂志,2006,22(1):96-98. 被引量:1
  • 3高艳虹,李定国.基因治疗靶向方法的研究进展[J].中华内科杂志,2006,45(5):432-434. 被引量:7
  • 4梁春敏,钟翠平,郑宁,刘彬彬,孙瑞霞,吴欣,刘银坤,叶胜龙.SLC基因修饰树突状细胞及不同免疫方式抗肿瘤作用探讨[J].中国免疫学杂志,2006,22(8):721-726. 被引量:3
  • 5Schuler G, Schuler-Thumer B, Steinman R M. The use of dendritic cells in cancer immunotherapy [ J ]. Curr Opin Immunol, 2003, 15(2) : 138-147.
  • 6Chirico J, Trempe J P. Optimization of packaging of adenoassociated virus gene therapy vectors using plasmid transfections [J]. J Virol Methods, 1998, 76(1-2) : 31-41.
  • 7Zhang Y C, Powers M, Wasserfall C, et al. Immunity to adeno-associated virus serutypo 2 delivered transgenes imparted by genetic predisposition to autoimmunity [ J ] . Gene Ther, 2004, 11(3) : 233 -240.
  • 8Bancherean J, Steinman R M. Dendritic cells and the control of immunity [ J]. Nature, 1998, 392 (6673) : 245- 252.
  • 9Sallusto F, Lanzavecchia A. Efficient presentation soluble antigen by cultured human dendritic cells in maintained by granulocyte/macrophage colony-stimulating factor plus interlenkin 4 and downregulated by tumor recrosis factor alpha [ J ]. J Exp Med, 1994, 179 (4): 1109-1118.
  • 10Douglas C P, Virginia K, Wiliam W W, et al. Primary structure of the Aecquorea Victoria green fluorescent protein [J]. Gene, 1992, 111(2): 229-233.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部